Keith F Martin
Chief Executive Officer
Pharmaceutical
apitope
Belgium
Biography
Keith Martin, chief executive director of Apitope pharmaceuticals. He received Phd from University of Bath. He has held senior positions in R&D and corporate & business development as well as both executive and non-executive Board positions with management and leadership roles in UK, Belgium, USA & Spain. . He led the completion of two successful Phase I clinical trials in multiple sclerosis patients, closed the €10 million Series A (October 2008) and €12 million Series B (September 2015) financings and a €150 million+ licensing deal in January 2009.
Research Interest
Pharmaceuticals and business Development
